Human Genome

Direct Phased Genome Assembly Using Nighthawk on HiFi Reads

4 monthes ago   |   By Pacific Biosciences

By Zev Kronenberg, Senior Engineer of Bioinformatics at PacBio
Since the introduction of HiFi reads the community has embraced these long and highly accurate reads for human genome assembly and paralog resolution. At PacBio, the assembly team is working to build on the accuracy of HiFi data for direct phasing during assembly.
Figure 1. The PacBio assembly team. From left to right, James Drake, Zev Kronenberg , Derek Barnett , Chris Dunn, and Ivan Sović
In diploid organisms, phasing an assembly means separating the maternally and paternally inherited copies of each chromosome, known as...
Read more ...

 


Search by Tags

   Human Genome      Genome      Genomics      Bioinformatic      Bioinformatics      Chromosomes      Engineering      Blog      De Bruijn graphs      Diploid assembly      Nighthawk      Phased assembly  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of...

SAN DIEGO, May 26, 2020 - Sorrento Therapeutics, Inc. today announced it has received clearance from the U.S. Food and Drug Administration for its investigational new drug... Read more ...

Public Disclosure of COVID-19 Cases Is More Effective than Lockdowns

Read more ...

Gerald Joyce elected to Royal Swedish Academy of Sciences

LA JOLLA-Salk Professor Gerald Joyce, a pioneer in the field of in vitro evolution, has been elected to the prestigious Royal Swedish Academy of Sciences as a foreign member... Read more ...

Sugars that coat proteins are a possible drug target for pancreatitis

LA JOLLA-Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary... Read more ...

Scientists Identify Climate Change as Major Contributor to Record-Breaking...

Read more ...

Research Scientist

We are seeking a motivated candidate to work within our antibody discovery team generating, troubleshooting and testing polyclonal, monoclonal, and single-domain antibodies... Read more ...

Three-dimensional liver models: state of the art and their application for...

ABSTRACT While alternative methods for toxicity testing using re-constructed human skin and cornea have been written into guidelines and adopted by regulatory authorities... Read more ...